Eric Crosbie, Ph.D., MA

Assistant Professor
Eric Crosbie

Contact Information

Degrees

  • Ph.D., Politics/Public Health - University of California, Santa Cruz 2016
  • M.A., International Relations - San Francisco State University 2010

Biography

Dr. Crosbie is a political scientist who examines commercial determinants of health and public health policy. His research focuses on non-communicable diseases (NCDs) and examines how commercial industries like tobacco and food and beverage industries are a key driver of the NCD epidemic and how they influence NCD regulations. Dr. Crosbie's research is local in analyzing smoke-free environments and sugar sweetened beverage taxation regulations in the U.S. as well as global in examining tobacco and nutrition packaging and labeling policies and the impact of trade on health in Latin America, the Caribbean, Europe, Africa and the Pacific. Dr. Crosbie has both local and international experience collaborating with health organizations and health advocates to educate and disseminate academic research findings to policymakers, including publishing research in Spanish to reach wider audiences. Overall his research is multi-disciplinary combining elements of political science, public health, law, and business to examine public health policy both locally and globally.

Research and teaching interests: Commercial determinants of health, health policy, global health, tobacco control, nutrition policy, sugar sweetened beverages, trade and health, international relations, transnational corporations, political institutions, Latin America.

Publications

Selected Publications

  • Crosbie E, Eckford R, Bialous S. Containing diffusion: the tobacco industry's multipronged trade strategy to block tobacco standardised packaging. Tobacco control. 2018 Apr 21.
  • Crosbie E, Thomson G. Regulatory chills: tobacco industry legal threats and the politics of tobacco standardised packaging in New Zealand. N Z Med J. 2018 Apr 13;131(1473):25-41.
  • Crosbie E, Thomson G, Freeman B, Bialous S. Advancing progressive health policy to reduce NCDs amidst international commercial opposition: Tobacco standardised packaging in Australia. Glob Public Health. 2018 Feb 27:1-14
  • Crosbie E, Sosa P, Glantz S.A. Defending strong tobacco packaging and labeling regulations in Uruguay: transnational tobacco control network vs. Philip Morris International. Tob Control. 2018 Mar;27(2):185-194. (Also translated and available in Spanish.)
  • Crosbie E, Sosa P, Glantz S.A. Costa Rica’s successful implementation of the Framework Convention on Tobacco Control: Overcoming decades of industry dominance, Salud Publica Mex. 2016;58(1). (Also translated and available in Spanish.)
  • Crosbie E, Gonzalez M, Glantz S.A. Health preemption behind closed doors: Trade agreements and fast track authority. Am J Public Health. 2014; e1-e7.
  • Crosbie E, Glantz S.A. Tobacco industry argues domestic trademark laws and international treaties preclude cigarette health warning labels, despite consistent legal advice that the argument is invalid. Tob Control. May 2014;23(3):e7.
  • Hiilamo H, Crosbie E, Glantz, S.A. The evolution of health warning labels on cigarette packs: the role of precedents, and tobacco industry strategies to block diffusion. Tob Control. Jan 2014;23(1):e2.
  • Crosbie E, Sebrié E.M, Glantz S.A. Tobacco industry success in Costa Rica: the importance of FCTC article 5.3. Salud Publica Mex. 2012;54(1):28-38. (Also translated and available in Spanish.)